Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

NCT04452591 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

190

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Muscle Invasive Bladder Cancer
High-grade Ta/ T1 Papillary Disease Bladder Cancer

Interventions

BIOLOGICAL: Cretostimogene Grenadenorepvec
OTHER: n-dodecyl-B-D-maltoside

Sponsor

CG Oncology, Inc.